Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Home

Showing results (221-230 of 231) with videos related to

Pageof 24
Sort By:
Diabetes, Obesity & Metabolism|April 28, 2026
The Silver Jubilee (2025) of Insulin Glargine: Introducing the Era of Long-Acting Insulin Analogues for Diabetes MellitusGeremia B Bolli, Philip D Home, Mauro Lepore, et al.
Diabetes, Obesity & Metabolism|May 17, 2018
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open-label clinical trialPhilip D Home, Raymond L H Lam, Wendy L Carofano, et al.
American Heart Journal|July 31, 2013
Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: study design and conductRenato D Lopes, Sheila Dickerson, Gail Hafley, et al.
American Heart Journal|July 31, 2013
Results of a reevaluation of cardiovascular outcomes in the RECORD trialKenneth W Mahaffey, Gail Hafley, Sheila Dickerson, et al.
Diabetes Care|January 29, 2011
Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargineKåre I Birkeland, Philip D Home, Ulrich Wendisch, et al.
Diabetes, Obesity & Metabolism|May 16, 2018
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open-label clinical trialPriscilla A Hollander, Wendy L Carofano, Raymond L H Lam, et al.
Diabetes Care|May 13, 2011
Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) studyMichael R MacDonald, Mark C Petrie, Philip D Home, et al.
Diabetes Care|October 1, 2015
Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert ForumWilliam T Cefalu, George A Bray, Philip D Home, et al.
Diabetes Care|May 25, 2013
Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert ForumItamar Raz, Matthew C Riddle, Julio Rosenstock, et al.
Clinical Transplantation|May 10, 2005
Guidelines for the treatment and management of new-onset diabetes after transplantationAlan Wilkinson, Jaime Davidson, Francesco Dotta, et al.
Pageof 24

Showing results (221-230 of 231) with videos related to

Sort By:
Pageof 24
Diabetes, Obesity & Metabolism|April 28, 2026
The Silver Jubilee (2025) of Insulin Glargine: Introducing the Era of Long-Acting Insulin Analogues for Diabetes MellitusGeremia B Bolli, Philip D Home, Mauro Lepore, et al.
Diabetes, Obesity & Metabolism|May 17, 2018
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open-label clinical trialPhilip D Home, Raymond L H Lam, Wendy L Carofano, et al.
American Heart Journal|July 31, 2013
Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: study design and conductRenato D Lopes, Sheila Dickerson, Gail Hafley, et al.
American Heart Journal|July 31, 2013
Results of a reevaluation of cardiovascular outcomes in the RECORD trialKenneth W Mahaffey, Gail Hafley, Sheila Dickerson, et al.
Diabetes Care|January 29, 2011
Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargineKåre I Birkeland, Philip D Home, Ulrich Wendisch, et al.
Diabetes, Obesity & Metabolism|May 16, 2018
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open-label clinical trialPriscilla A Hollander, Wendy L Carofano, Raymond L H Lam, et al.
Diabetes Care|May 13, 2011
Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) studyMichael R MacDonald, Mark C Petrie, Philip D Home, et al.
Diabetes Care|October 1, 2015
Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert ForumWilliam T Cefalu, George A Bray, Philip D Home, et al.
Diabetes Care|May 25, 2013
Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert ForumItamar Raz, Matthew C Riddle, Julio Rosenstock, et al.
Clinical Transplantation|May 10, 2005
Guidelines for the treatment and management of new-onset diabetes after transplantationAlan Wilkinson, Jaime Davidson, Francesco Dotta, et al.
Pageof 24